Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
101.00    -2.20 (-2.13%)
Bid:
100.00
Ask:
100.00
Spread: 0.00 (0.00%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

14 Nov 2008 07:00

RNS Number : 1486I
Yule Catto & Co PLC
14 November 2008
 



Yule Catto & Co plc 

Interim Management Statement

Whilst 2008 started positively, the slowdown in the global economy has become ever more evident as the year has progressed.

In Polymer Chemicals, our latex business in both Europe and the Far East enjoyed good volumes particularly in nitrile. The reduced demand from the construction and coatings Industries has resulted in declining volumes in our dispersions business in Europe and South Africa. However, we have continued to see good growth in these products over the course of the year in both the Middle East and the Far East. Margins remained under pressure in the third quarter as monomer prices generally increased, though these costs are now starting to fall.

Whilst we see the Pharma business as non cyclical, we have seen volume reductions through the second half, as customers have de-stocked in response to the economic downturn, and we now expect Pharma full year profits to be below 2007. The Italian plant remains on track for closure in mid 2009 and we expect to see the benefit of that in the business results through next year.

The restructured Impact portfolio continues to perform ahead of last year, and the successful divestments of James Robinson in the first half and Holliday Pigments in the third quarter have allowed us to substantially reduce our Group borrowings.

Overall, in line with our view at the half year, we continue to expect our full year underlying profit before tax to be modestly ahead of 2007.

14 November 2008

 ENQUIRIES:

 

YULE CATTO

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Group Finance Director 

 

COLLEGE HILL 

Tel: 020 7457 2020 

Gareth David

email: gareth.david@collegehill.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFIDLALVLIT
Date   Source Headline
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue
7th Sep 20237:00 amRNSHalf-year results
18th Jul 20237:00 amRNSPost-close trading update
12th Jul 20233:17 pmRNSAppointment of Non-Executive Director
28th Jun 202312:37 pmRNSDirector/PDMR Shareholding
28th Jun 202312:36 pmRNSDirector/PDMR Shareholding
22nd Jun 202310:20 amRNSDirector/PDMR Shareholding
16th May 20234:00 pmRNSResult of AGM
16th May 20237:00 amRNSAGM trading update
12th May 20231:08 pmRNSDirector/PDMR Shareholding
12th May 20231:06 pmRNSDirector/PDMR Shareholding
13th Apr 202310:02 amRNSHolding(s) in Company
12th Apr 20235:52 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSRefinancing
28th Feb 20233:33 pmRNSDisposal
31st Jan 20237:00 amRNSPost-close update for the year ended 31 Dec 2022
11th Jan 202311:30 amRNSResult of General Meeting
16th Dec 202212:12 pmRNSPublication of Circular &Notice of General Meeting
13th Dec 20227:00 amRNSProposed Sale of Laminates, Films & Coated Fabrics
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSBoard changes
29th Nov 202211:16 amRNSOutcome of European Commission investigation
1st Nov 20222:53 pmRNSHolding(s) in Company
27th Oct 202210:27 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSCovenant relaxation to the end of 2023 agreed
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSInvestor Seminar
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 202210:40 amRNSDirector/PDMR Shareholding
4th Oct 202210:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.